These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37748266)

  • 1. Association of substance use with outcomes in mildly ill COVID-19 outpatients.
    Pobee R; Cable T; Chan D; Herrick J; Durkalski-Mauldin V; Korley F; Callaway C; Del Rios M
    Am J Emerg Med; 2023 Dec; 74():27-31. PubMed ID: 37748266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
    Korley FK; Durkalski-Mauldin V; Yeatts SD; Schulman K; Davenport RD; Dumont LJ; El Kassar N; Foster LD; Hah JM; Jaiswal S; Kaplan A; Lowell E; McDyer JF; Quinn J; Triulzi DJ; Van Huysen C; Stevenson VLW; Yadav K; Jones CW; Kea B; Burnett A; Reynolds JC; Greineder CF; Haas NL; Beiser DG; Silbergleit R; Barsan W; Callaway CW;
    N Engl J Med; 2021 Nov; 385(21):1951-1960. PubMed ID: 34407339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.
    Ortigoza MB; Yoon H; Goldfeld KS; Troxel AB; Daily JP; Wu Y; Li Y; Wu D; Cobb GF; Baptiste G; O'Keeffe M; Corpuz MO; Ostrosky-Zeichner L; Amin A; Zacharioudakis IM; Jayaweera DT; Wu Y; Philley JV; Devine MS; Desruisseaux MS; Santin AD; Anjan S; Mathew R; Patel B; Nigo M; Upadhyay R; Kupferman T; Dentino AN; Nanchal R; Merlo CA; Hager DN; Chandran K; Lai JR; Rivera J; Bikash CR; Lasso G; Hilbert TP; Paroder M; Asencio AA; Liu M; Petkova E; Bragat A; Shaker R; McPherson DD; Sacco RL; Keller MJ; Grudzen CR; Hochman JS; Pirofski LA; ; Parameswaran L; Corcoran AT; Rohatgi A; Wronska MW; Wu X; Srinivasan R; Deng FM; Filardo TD; Pendse J; Blaser SB; Whyte O; Gallagher JM; Thomas OE; Ramos D; Sturm-Reganato CL; Fong CC; Daus IM; Payoen AG; Chiofolo JT; Friedman MT; Wu DW; Jacobson JL; Schneider JG; Sarwar UN; Wang HE; Huebinger RM; Dronavalli G; Bai Y; Grimes CZ; Eldin KW; Umana VE; Martin JG; Heath TR; Bello FO; Ransford DL; Laurent-Rolle M; Shenoi SV; Akide-Ndunge OB; Thapa B; Peterson JL; Knauf K; Patel SU; Cheney LL; Tormey CA; Hendrickson JE
    JAMA Intern Med; 2022 Feb; 182(2):115-126. PubMed ID: 34901997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between patient-reported onset-to-door time and mortality in patients hospitalized with COVID-19 disease.
    Yadav KN; Hemmons J; Snider CK; Patel A; Childs M; Delgado MK
    Am J Emerg Med; 2024 Mar; 77():169-176. PubMed ID: 38157591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Social and Behavioral Risk Factors With Mortality Among US Veterans With COVID-19.
    Kelly JD; Bravata DM; Bent S; Wray CM; Leonard SJ; Boscardin WJ; Myers LJ; Keyhani S
    JAMA Netw Open; 2021 Jun; 4(6):e2113031. PubMed ID: 34106264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Substance Use Among Adult Emergency Department Patients: Prevalence, Severity, and Need for Intervention.
    Beaudoin FL; Baird J; Liu T; Merchant RC
    Acad Emerg Med; 2015 Nov; 22(11):1307-15. PubMed ID: 26473942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent plasma for people with COVID-19: a living systematic review.
    Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
    Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
    JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City.
    Ogedegbe G; Ravenell J; Adhikari S; Butler M; Cook T; Francois F; Iturrate E; Jean-Louis G; Jones SA; Onakomaiya D; Petrilli CM; Pulgarin C; Regan S; Reynolds H; Seixas A; Volpicelli FM; Horwitz LI
    JAMA Netw Open; 2020 Dec; 3(12):e2026881. PubMed ID: 33275153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific disparities in COVID-19 outcomes.
    Rafique Z; Durkalski-Mauldin V; Peacock WF; Yadav K; Reynolds JC; Callaway CW
    J Am Coll Emerg Physicians Open; 2024 Feb; 5(1):e13110. PubMed ID: 38283615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
    Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N;
    JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial.
    Gharbharan A; Jordans C; Zwaginga L; Papageorgiou G; van Geloven N; van Wijngaarden P; den Hollander J; Karim F; van Leeuwen-Segarceanu E; Soetekouw R; Lammers J; Postma D; Kampschreur L; Groeneveld G; Swaneveld F; van der Schoot CE; Götz H; Haagmans B; Koopmans M; Bogers S; Geurtsvankessel C; Zwaginga JJ; Rokx C; Rijnders B;
    Clin Microbiol Infect; 2023 Feb; 29(2):208-214. PubMed ID: 36007870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.
    Kendall CE; Boucher LM; Mark AE; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; Rose T; LeBlanc S; Tyndall M; Lee OM; Bayoumi AM
    Harm Reduct J; 2017 May; 14(1):16. PubMed ID: 28494791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.